<p>The first report of a novel IncHI1B <em>bla</em><sub>SIM-1</sub>-carrying megaplasmid pSIM-1-BJ01 from a clinical <em>Klebsiella pneumoniae</em> isolate</p>
Abstract:Background:
A rare member of metallo-β-lactamases genes,
bla
SIM-1
, carried by a 316-kb plasmid designated pSIM-1-BJ01 was isolated from a clinical cephalosporins- and carbapenem-resistant
Klebsiella
pneumoniae
13624. This is the first sequence report of a transferable
bla
SIM-1
-carrying conjugative plasmid isolated from
K. pneumoniae
.
Purpose:
… Show more
“…Another MBL, SIM-1 (Seoul imipenemase-1) was isolated in Korea [120] and was carried on a gene cassette inserted into a class 1 integron, found in A. baumannii strains isolated in sputum and the urine of patients with pneumonia and urinary tract infections, respectively. In 2019, the spread of bla SIM-1 to Enterobacteriaceae has been suggested after a report from China indicating a mega-plasmid harboring this gene from a clinical K. pneumoniae isolate [121]. More recently, described MBLs include DIM-1 (Dutch imipenemase-1) [122], KHM-1 (Kyorin University Hospital MBL-1) [123], and TMB-1 (Triploi MBL-1) [124] that have been reported on occasional encounters.…”
Section: Ambler Class B Carbapenemases (Metallo-β-lactamases)mentioning
Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent the most potent β-lactamases, which hydrolyze a broad variety of β-lactams, including carbapenems, cephalosporins, penicillin, and aztreonam. The major issues associated with carbapenemase production are clinical due to compromising the activity of the last resort antibiotics used for treating serious infections, and epidemiological due to their dissemination into various bacteria across almost all geographic regions. Carbapenemase-producing Enterobacteriaceae have received more attention upon their first report in the early 1990s. Currently, there is increased awareness of the impact of nonfermenting bacteria, such as Acinetobacter baumannii and Pseudomonas aeruginosa, as well as other Gram-negative bacteria that are carbapenemase-producers. Outside the scope of clinical importance, carbapenemases are also detected in bacteria from environmental and zoonotic niches, which raises greater concerns over their prevalence, and the need for public health measures to control consequences of their propagation. The aims of the current review are to define and categorize the different families of carbapenemases, and to overview the main lines of their spread across different bacterial groups.
“…Another MBL, SIM-1 (Seoul imipenemase-1) was isolated in Korea [120] and was carried on a gene cassette inserted into a class 1 integron, found in A. baumannii strains isolated in sputum and the urine of patients with pneumonia and urinary tract infections, respectively. In 2019, the spread of bla SIM-1 to Enterobacteriaceae has been suggested after a report from China indicating a mega-plasmid harboring this gene from a clinical K. pneumoniae isolate [121]. More recently, described MBLs include DIM-1 (Dutch imipenemase-1) [122], KHM-1 (Kyorin University Hospital MBL-1) [123], and TMB-1 (Triploi MBL-1) [124] that have been reported on occasional encounters.…”
Section: Ambler Class B Carbapenemases (Metallo-β-lactamases)mentioning
Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent the most potent β-lactamases, which hydrolyze a broad variety of β-lactams, including carbapenems, cephalosporins, penicillin, and aztreonam. The major issues associated with carbapenemase production are clinical due to compromising the activity of the last resort antibiotics used for treating serious infections, and epidemiological due to their dissemination into various bacteria across almost all geographic regions. Carbapenemase-producing Enterobacteriaceae have received more attention upon their first report in the early 1990s. Currently, there is increased awareness of the impact of nonfermenting bacteria, such as Acinetobacter baumannii and Pseudomonas aeruginosa, as well as other Gram-negative bacteria that are carbapenemase-producers. Outside the scope of clinical importance, carbapenemases are also detected in bacteria from environmental and zoonotic niches, which raises greater concerns over their prevalence, and the need for public health measures to control consequences of their propagation. The aims of the current review are to define and categorize the different families of carbapenemases, and to overview the main lines of their spread across different bacterial groups.
“…Similar results were reported for the SIM-1 gene in A. baumannii 10 in Iraq 22 and in Egypt, 20 in P. aeruginosa and recently in Egypt 23 and K. pneumoniae with ST23 strain carrying SIM-1 in China. 24 The GIM-1 and SIM-1 genes were transferred to Sudan, these can be broadly categorized into issues of emergence, spread, and clonal expansion with diversity, which include natural genetic diversification caused by mutation, horizontal gene transfer among other species, an increase in international travel and patient transfer between countries raising the possibility for further dissemination of strains carrying resistant genes. There is a need for further investigation regarding travel history, as three of the patients had previously travelled.…”
Purpose
The aim of this study was to detect multidrug resistant GIM-1 and SIM-1 producing
Enterobacteriaceae
clinical isolates from hospitalized patients across three Khartoum State Teaching Hospitals, Sudan.
Patients and Methods
From May 2018 to October 2019,
Enterobacteriaceae
clinical isolates from inpatients admitted to different Khartoum state hospitals. Genes for carbapenemase (GIM-1 and SIM-1) were amplified by polymerase chain reaction (PCR). Agar dilution method was used to determine MICs for imipenem and meropenem after antimicrobial susceptibility testing.
Results
Five (1.29%) isolates of
Enterobacteriaceae
[2 (0.51%)
Escherichia coli
isolates produce GIM-1, 2 (0.51%)
Klebsiella pneumoniae
isolates (one [0.25%] of each produce of GIM-1 and of SIM-1), and 1 (0.25%)
Enterobacter cloacae
isolate produce GIM-1]. Susceptibility profiling of the isolates showed a low-level resistance to imipenem and meropenem MICs (8, 16 and 32 μg/mL). It also had resistance to ampicillin, extended-spectrum cephalosporin’s, aztreonam, and amoxicillin-clavulanate and with the two
K. pneumoniae
strains showing resistance to colistin.
Conclusion
We report the emergence of four GIM-1 producing
Enterobacteriaceae
strains and one strain of SIM-1 producing
K. pneumoniae
genes, isolated from hospitalized patients, with a high resistance pattern to antimicrobial agents. Whole-genome sequencing (WGS) is necessary for precise identification of clonal diversity backgrounds of acquired carbapenemase genes in diagnostic laboratories as the number of cases of carbapenem resistant
Enterobacteriaceae
infection increases annually.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.